Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Radnet Inc (RDNT)

Radnet Inc (RDNT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,897,200
  • Shares Outstanding, K 52,700
  • Annual Sales, $ 1,072 M
  • Annual Income, $ -14,840 K
  • 60-Month Beta 1.67
  • Price/Sales 1.63
  • Price/Cash Flow 10.95
  • Price/Book 5.82
Trade RDNT with:

Options Overview

Details
  • Implied Volatility 47.96%
  • Historical Volatility 62.96%
  • IV Percentile 48%
  • IV Rank 15.75%
  • IV High 125.58% on 07/08/20
  • IV Low 33.45% on 01/15/21
  • Put/Call Vol Ratio 0.11
  • Today's Volume 270
  • Volume Avg (30-Day) 506
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 5,719
  • Open Int (30-Day) 3,656

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.14
  • Number of Estimates 2
  • High Estimate 0.15
  • Low Estimate 0.13
  • Prior Year -0.16
  • Growth Rate Est. (year over year) +187.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.97 +44.60%
on 05/18/21
36.34 -4.62%
on 06/17/21
+11.27 (+48.18%)
since 05/17/21
3-Month
20.74 +67.12%
on 03/25/21
36.34 -4.62%
on 06/17/21
+12.08 (+53.50%)
since 03/17/21
52-Week
13.49 +156.93%
on 09/25/20
36.34 -4.62%
on 06/17/21
+18.94 (+120.48%)
since 06/17/20

Most Recent Stories

More News
RadNet (RDNT) Soars 10%: Is Further Upside Left in the Stock?

RadNet (RDNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the...

RDNT : 34.60 (-3.89%)
RadNet, Inc. to Present at the Jefferies 2021 Virtual Healthcare Conference on June 3, 2021

RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced...

RDNT : 34.60 (-3.89%)
RadNet, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 10, 2021 / RadNet, Inc. (NASDAQ:RDNT) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 10, 2021 at 10:30 AM Eastern...

RDNT : 34.60 (-3.89%)
RadNet (RDNT) Q1 Earnings and Revenues Beat Estimates

RadNet (RDNT) delivered earnings and revenue surprises of 180.00% and 7.05%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

RDNT : 34.60 (-3.89%)
RadNet Reports First Quarter Financial Results, Including Record First Quarter Revenue, Adjusted EBITDA(1) and Net Income, and Revises Upwards 2021 Financial Guidance Ranges

RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 346 owned and/or operated outpatient imaging...

RDNT : 34.60 (-3.89%)
RadNet (RDNT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

RDNT : 34.60 (-3.89%)
Shields Health Care Group Deploys eRAD RIS to Streamline Efficiency Across Enterprise

, /PRNewswire/ -- eRAD, a subsidiary of RadNet, Inc. (NASDAQ: RDNT), a leading provider of RIS (Radiology Information System) and PACS (Picture Archiving and Communication System) solutions, announced...

RDNT : 34.60 (-3.89%)
RadNet, Inc. Announces the Date of its First Quarter 2021 Financial Results Conference Call

RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today...

RDNT : 34.60 (-3.89%)
RadNet Announces the Closing of Its Previously Announced Refinancing Transaction

RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and/or operated outpatient imaging centers, today announced...

RDNT : 34.60 (-3.89%)
RadNet's Artificial Intelligence Subsidiary, DeepHealth, Announces FDA Clearance for its AI Mammography Triage Software

RadNet, Inc., (NASDAQ: RDNT) today announced that its subsidiary DeepHealth, a leading developer of artificial intelligence (AI) for mammography interpretation, has received FDA clearance for its mammography...

RDNT : 34.60 (-3.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT,...

See More

Key Turning Points

3rd Resistance Point 40.42
2nd Resistance Point 38.25
1st Resistance Point 37.13
Last Price 34.60
1st Support Level 33.84
2nd Support Level 31.67
3rd Support Level 30.55

See More

52-Week High 36.34
Last Price 34.60
Fibonacci 61.8% 27.61
Fibonacci 50% 24.92
Fibonacci 38.2% 22.22
52-Week Low 13.49

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar